United States · Venture startup
Funding summaryUpdated 26 Oct 2026
$90Mraised across 4 rounds since 2011, from 4 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
No investor was named in the report.
From a historical funding recordSEC filing: $15M sold, first sale Jul 2015
From a historical funding record
Reported by bizjournals.com
No investor was named in the report.
Reported by sec.govSEC filing: $12M sold, first sale Feb 2011
From the SEC filings it signed: 1 on the team.
On the board, as filediAlan ColowickDaniel BeckerLewis J. ShusterNassim J. UsmanPeter J. ThompsonSimeon GeorgeSrinivas Akkaraju
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
OrbiMed
Morgenthaler Ventures
SR One
New Leaf Venture Partners
Mission Bay Capital
Sofinnova InvestmentsMissing a round, or an investor who was in one? Tell us.
Principia BioPharma's investors include OrbiMed, Morgenthaler Ventures, SR One, New Leaf Venture Partners and Mission Bay Capital, and 1 more on record.
Principia BioPharma has raised $90M across 4 rounds since 2011.
Principia BioPharma's most recent round was a Venture of $15M in Aug 2015.
Principia BioPharma's largest round on record is $50M (Series B), in Apr 2014.
Principia BioPharma's first round on record, in Oct 2012, was backed by OrbiMed, Morgenthaler Ventures and SR One and 2 others.
Principia BioPharma's latest named round is a Venture, in Aug 2015.
Principia BioPharma is based in the United States.
In the same sector, and raised in the last eighteen months.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.
United States · 
